Home/Arvinas/Craig Crews
CC

Craig Crews

Founder, Executive Director, Chief Scientific Advisor

Arvinas

Therapeutic Areas

Arvinas Pipeline

DrugIndicationPhase
Vepdegestrant (ARV-471)ER+/HER2- Advanced Breast CancerPhase 3
ARV-766Metastatic Castration-Resistant Prostate CancerPhase 2
Bavdegalutamide (ARV-110)Metastatic Castration-Resistant Prostate CancerPhase 2
ARV-102Parkinson's DiseasePhase 1
ARV-393Undisclosed OncologyPhase 1
ARV-6723Undisclosed OncologyPhase 1
ARV-806Undisclosed OncologyPhase 1
ARV-027Undisclosed OncologyPhase 1